TherapeuticsMD, Inc.
TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2017-11-1316:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-005435 |
| 2017-11-0717:53 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001387131-17-005313 |
| 2017-11-0606:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-005292 |
| 2017-10-0406:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-004944 |
| 2017-09-2807:37 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-17-296671 |
| 2017-09-2506:56 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-004745 |
| 2017-09-1206:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-004625 |
| 2017-08-1016:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-004045 |
| 2017-08-0317:28 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001387131-17-003894 |
| 2017-08-0316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-17-003882 |
| 2017-07-1707:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-003644 |
| 2017-06-1916:30 ET | 8-K | 5.07 Shareholder vote results | 0001387131-17-003317 |
| 2017-05-3117:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-003091 |
| 2017-05-0807:58 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001387131-17-002494 |
| 2017-05-0318:01 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001387131-17-002419 |
| 2017-05-0216:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-17-002408 |
| 2017-04-2517:01 ET | DEF 14A | Proxy statementPeriod 2017-06-16 | 0001387131-17-002244 |
| 2017-04-1008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001387131-17-001997 |
| 2017-03-2217:03 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-17-001567 |
| 2017-03-0108:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-001117 |
| 2017-02-2816:35 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001387131-17-001111 |
| 2017-02-2306:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-17-001038 |
| 2017-01-0916:41 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-000136 |
| 2016-12-0816:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-16-008405 |
| 2016-12-0516:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-16-008355 |
| 2016-11-0416:37 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001387131-16-007716 |
| 2016-11-0316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-16-007692 |
| 2016-09-2606:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-16-007059 |
| 2016-09-1917:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-16-007014 |
| 2016-08-2206:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-16-006711 |
| 2016-08-0521:11 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001387131-16-006337 |
| 2016-08-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-16-006326 |
| 2016-07-0717:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-16-005974 |
| 2016-06-2917:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-16-005927 |
| 2016-06-2016:32 ET | 8-K | 5.07 Shareholder vote results | 0001387131-16-005868 |
| 2016-05-0516:31 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001387131-16-005278 |
| 2016-05-0406:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-16-005241 |
| 2016-05-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-16-005235 |
| 2016-04-2806:06 ET | DEF 14A | Proxy statementPeriod 2016-06-16 | 0001193125-16-560833 |
| 2016-03-0716:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-16-004494 |
| 2016-02-2616:33 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001387131-16-004361 |
| 2016-02-2516:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-16-004340 |
| 2016-01-1208:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-16-427327 |
| 2015-12-2216:48 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001387131-15-003704 |
| 2015-12-0716:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-15-003552 |
| 2015-11-1708:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-15-003452 |
| 2015-11-0516:15 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001387131-15-003188 |
| 2015-11-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-15-003174 |
| 2015-10-1307:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-15-002981 |
| 2015-08-1708:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-15-002556 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.